Dimensional Fund Advisors LP Acquires 1,754 Shares of Waters Co. (WAT)
Dimensional Fund Advisors LP lifted its holdings in shares of Waters Co. (NYSE:WAT) by 0.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 210,835 shares of the medical instruments supplier’s stock after acquiring an additional 1,754 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Waters were worth $37,848,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also made changes to their positions in the company. Oppenheimer Asset Management Inc. lifted its stake in Waters by 0.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 2 shares in the last quarter. ETF Managers Group LLC purchased a new stake in Waters in the 2nd quarter worth approximately $106,000. Intellectus Partners LLC lifted its stake in Waters by 4.9% in the 2nd quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 31 shares in the last quarter. Edmond DE Rothschild Holding S.A. purchased a new stake in Waters in the 2nd quarter worth approximately $160,000. Finally, Acrospire Investment Management LLC lifted its stake in Waters by 117.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 926 shares of the medical instruments supplier’s stock worth $170,000 after purchasing an additional 500 shares in the last quarter. Institutional investors own 92.12% of the company’s stock.
Shares of Waters Co. (WAT) opened at $207.73 on Friday. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. The firm has a market cap of $16,520.00, a price-to-earnings ratio of 30.64, a PEG ratio of 2.71 and a beta of 0.82. Waters Co. has a 52-week low of $137.56 and a 52-week high of $210.08.
Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.03. The firm had revenue of $565.58 million for the quarter, compared to analysts’ expectations of $555.25 million. Waters had a net margin of 24.34% and a return on equity of 23.61%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $1.57 EPS. sell-side analysts expect that Waters Co. will post 7.42 earnings per share for the current year.
Several analysts have issued reports on the stock. Goldman Sachs Group assumed coverage on shares of Waters in a research note on Tuesday, September 26th. They issued a “hold” rating and a $180.00 target price on the stock. Barclays increased their target price on shares of Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 25th. Zacks Investment Research upgraded shares of Waters from a “hold” rating to a “buy” rating and set a $211.00 target price on the stock in a research note on Monday, October 23rd. Citigroup reiterated a “neutral” rating and issued a $180.00 target price on shares of Waters in a research note on Wednesday, October 25th. Finally, Morgan Stanley reiterated an “underweight” rating and issued a $192.00 target price (up from $183.00) on shares of Waters in a research note on Friday, October 6th. Eleven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $197.33.
In other news, Director Joann A. Reed sold 1,386 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $194.07, for a total transaction of $268,981.02. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Rohit Khanna sold 26,913 shares of the firm’s stock in a transaction on Friday, October 27th. The shares were sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares in the company, valued at approximately $2,707,088.61. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 93,159 shares of company stock worth $18,412,172. Corporate insiders own 5.07% of the company’s stock.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.